 Munendra Tomar
Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Killer Cells, Natural | 3 | 2022 | 480 | 1.080 |
Why?
| | Lymphoma | 4 | 2022 | 237 | 0.960 |
Why?
| | Naproxen | 1 | 2026 | 21 | 0.930 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2026 | 153 | 0.860 |
Why?
| | Oncogene Proteins, Fusion | 2 | 2026 | 212 | 0.850 |
Why?
| | Prostatic Neoplasms | 3 | 2026 | 978 | 0.770 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2026 | 345 | 0.750 |
Why?
| | Aspirin | 1 | 2026 | 406 | 0.740 |
Why?
| | Lymphoma, T-Cell | 3 | 2017 | 29 | 0.640 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2022 | 409 | 0.560 |
Why?
| | Tumor Microenvironment | 3 | 2026 | 734 | 0.400 |
Why?
| | Macrophages | 3 | 2026 | 1507 | 0.250 |
Why?
| | Benzophenanthridines | 2 | 2015 | 10 | 0.230 |
Why?
| | Mice, Inbred BALB C | 6 | 2017 | 1261 | 0.220 |
Why?
| | Adenocarcinoma | 2 | 2022 | 925 | 0.210 |
Why?
| | Quantum Dots | 1 | 2024 | 37 | 0.200 |
Why?
| | Phytochemicals | 2 | 2021 | 13 | 0.200 |
Why?
| | Apoptosis | 5 | 2017 | 2440 | 0.200 |
Why?
| | Carcinogenesis | 3 | 2022 | 228 | 0.190 |
Why?
| | Azadirachta | 1 | 2022 | 3 | 0.190 |
Why?
| | Nanocapsules | 1 | 2022 | 14 | 0.180 |
Why?
| | Cell Line, Tumor | 5 | 2022 | 3542 | 0.180 |
Why?
| | Mice | 8 | 2026 | 18329 | 0.170 |
Why?
| | Cation Transport Proteins | 1 | 2022 | 118 | 0.160 |
Why?
| | Carica | 1 | 2020 | 1 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 111 | 0.160 |
Why?
| | Protein Kinase C | 1 | 2021 | 251 | 0.150 |
Why?
| | Transforming Growth Factor beta | 1 | 2022 | 474 | 0.150 |
Why?
| | Electromagnetic Radiation | 1 | 2019 | 3 | 0.150 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2022 | 218 | 0.150 |
Why?
| | Animals | 12 | 2026 | 38030 | 0.140 |
Why?
| | Autoantigens | 2 | 2022 | 427 | 0.130 |
Why?
| | Biological Products | 1 | 2021 | 257 | 0.130 |
Why?
| | Cell Growth Processes | 1 | 2017 | 48 | 0.130 |
Why?
| | Protein Kinase C-alpha | 1 | 2017 | 37 | 0.130 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 182 | 0.130 |
Why?
| | Neoplasm Transplantation | 1 | 2017 | 246 | 0.130 |
Why?
| | Interferon-gamma | 2 | 2017 | 784 | 0.120 |
Why?
| | Antineoplastic Agents | 4 | 2015 | 2214 | 0.120 |
Why?
| | Forkhead Transcription Factors | 1 | 2017 | 207 | 0.120 |
Why?
| | Tumor Cells, Cultured | 1 | 2017 | 886 | 0.120 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2016 | 75 | 0.110 |
Why?
| | Mice, Inbred C57BL | 1 | 2026 | 5983 | 0.110 |
Why?
| | Cell Proliferation | 4 | 2017 | 2507 | 0.110 |
Why?
| | Selenium | 1 | 2015 | 50 | 0.110 |
Why?
| | Tumor Burden | 1 | 2015 | 325 | 0.100 |
Why?
| | Metal Nanoparticles | 1 | 2015 | 80 | 0.100 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1132 | 0.100 |
Why?
| | Humans | 14 | 2026 | 145474 | 0.100 |
Why?
| | Cell Survival | 2 | 2015 | 1100 | 0.100 |
Why?
| | Carbon | 2 | 2024 | 176 | 0.090 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2012 | 177 | 0.090 |
Why?
| | Peptide Fragments | 1 | 2016 | 693 | 0.090 |
Why?
| | Anxiety | 1 | 2019 | 1118 | 0.090 |
Why?
| | Male | 8 | 2026 | 72842 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2024 | 2382 | 0.080 |
Why?
| | Immunity, Cellular | 1 | 2012 | 274 | 0.080 |
Why?
| | Prostate | 2 | 2022 | 158 | 0.080 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 534 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2019 | 1146 | 0.080 |
Why?
| | Signal Transduction | 3 | 2021 | 5216 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1996 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2013 | 1480 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2022 | 3922 | 0.060 |
Why?
| | Transcription Factors | 1 | 2013 | 1734 | 0.060 |
Why?
| | Ions | 1 | 2024 | 66 | 0.050 |
Why?
| | Metals | 1 | 2024 | 136 | 0.050 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 40 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2022 | 74 | 0.050 |
Why?
| | Transcriptional Regulator ERG | 1 | 2022 | 14 | 0.050 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2022 | 48 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2024 | 333 | 0.040 |
Why?
| | Aquatic Organisms | 1 | 2021 | 9 | 0.040 |
Why?
| | Serine Endopeptidases | 1 | 2022 | 128 | 0.040 |
Why?
| | Allosteric Regulation | 1 | 2021 | 99 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2024 | 639 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 613 | 0.040 |
Why?
| | Databases, Chemical | 1 | 2020 | 9 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2021 | 267 | 0.040 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2022 | 337 | 0.040 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2020 | 178 | 0.040 |
Why?
| | Maze Learning | 1 | 2019 | 105 | 0.040 |
Why?
| | Plant Leaves | 1 | 2020 | 131 | 0.040 |
Why?
| | Molecular Structure | 1 | 2020 | 486 | 0.040 |
Why?
| | Zinc | 1 | 2022 | 306 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 519 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1443 | 0.030 |
Why?
| | Corticosterone | 1 | 2019 | 241 | 0.030 |
Why?
| | Neoplasms | 1 | 2013 | 2906 | 0.030 |
Why?
| | Immunologic Factors | 1 | 2020 | 260 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2022 | 728 | 0.030 |
Why?
| | Amygdala | 1 | 2019 | 199 | 0.030 |
Why?
| | Cell Death | 1 | 2019 | 382 | 0.030 |
Why?
| | Hydrolysis | 1 | 2017 | 197 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 477 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2017 | 451 | 0.030 |
Why?
| | CD28 Antigens | 1 | 2016 | 59 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 442 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2022 | 1140 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2017 | 855 | 0.030 |
Why?
| | Staurosporine | 1 | 2015 | 22 | 0.030 |
Why?
| | Caspase 9 | 1 | 2015 | 55 | 0.030 |
Why?
| | Cytochromes c | 1 | 2015 | 53 | 0.030 |
Why?
| | Macrophage Activation | 1 | 2016 | 181 | 0.030 |
Why?
| | Interleukin-2 | 1 | 2016 | 440 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2015 | 194 | 0.030 |
Why?
| | Caspase 3 | 1 | 2015 | 242 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 529 | 0.030 |
Why?
| | Cell Communication | 1 | 2016 | 328 | 0.030 |
Why?
| | Heat Shock Transcription Factors | 1 | 2013 | 21 | 0.030 |
Why?
| | Surface Properties | 1 | 2015 | 386 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2015 | 563 | 0.020 |
Why?
| | Disease Progression | 1 | 2021 | 2864 | 0.020 |
Why?
| | Particle Size | 1 | 2015 | 381 | 0.020 |
Why?
| | RNA Interference | 1 | 2015 | 475 | 0.020 |
Why?
| | Cell Movement | 1 | 2017 | 959 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 977 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2012 | 112 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1598 | 0.020 |
Why?
| | Blotting, Western | 1 | 2015 | 1179 | 0.020 |
Why?
| | Survival Rate | 1 | 2015 | 2090 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 2028 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1707 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 439 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5584 | 0.020 |
Why?
| | Female | 4 | 2024 | 78844 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1162 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2016 | 2046 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 7123 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 4148 | 0.010 |
Why?
|
|
Tomar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|